Cancer Drugs Market – 2019-2025
According to the World Health Organization (WHO), there are an estimated 18.1 million new cases of cancer registered in 2018. 9.6 million deaths were also recorded in 2018 which were regarded to cancer. Moreover, statistics also report increasing prevalence of cancer over the years. This has lead to increase in number of patients going for cancer therapies. But, cancer therapies have been associated with many side effects. Cancer supportive care drugs are used to alleviate the side effects of Cancer therapy. Hence increasing prevalence of cancer can be directly associated with the growth of this market. Rising disposable income and improved healthcare structure have also helped people to access the cancer supportive care drugs, which is also helping this market grow.
However, technological advancements in targeted therapy drugs, which have lesser side effects than traditional cancer therapy drugs, are being adopted at a faster rate. This has directly affected the growth of cancer supportive drugs market. Other factors like side effects from cancer supportive drugs and stringent regulatory processes have also contributed as restraining factors to this market.
Get Sample Report PDF >>
The following manufacturers are covered:
Sanofi and Pfizer
Johnson and Johnson
Scope of the Report
Cancer supportive care drugs are used to mitigate the harmful side effects of cancer treatment by protecting certain cells or organs. In the report, a detailed analysis of the cancer supportive care drugs market is provided. The market is segmented by drug class, and geography.
This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Opportunity mapping in terms of technological breakthroughs
Browse Report »
Key Market Trends
G-CSF is expected to register High Growth over the Forecast Period
G-CSF is a type of growth factor that helps the bone marrow to produce white blood cells to reduce the risk of infection after some types of cancer treatment. G-CSF also makes stem cells move from the bone marrow into the blood. Stem cells are the cells in the bone marrow that are responsible to the production of red blood cells, white cells and platelets.
G-CSF is administered to stimulate the bone marrow to produce stem cells and release them into the blood. The stem cells are then collected before proceeding to have high dose chemotherapy. The high dose of chemotherapy stops your bone marrow producing blood cells. Hence, the collected stem cells are used in stem cell transplant to restore the functioning of bone marrow.
As G-CSF helps to restore the functioning of bone marrow which is essential for the production of red blood cells, white cells and platelets, the drug class is being adopted widely. Owing to these factors and increasing prevalence of cancer (as per the Center for Disease Control and Prevention, 2018), this market is expected to grow in the forecast period.
North America dominates the market
North America has one of the highest prevalence of cancer in the world. According to National Institute of Health, prevalence of cancer in 2018 was estimated to be 439.2 per 100,000 in the United States. According to the Canadian Cancer Society, an estimated that 206,200 new cancer diagnosed and 80,800 deaths from cancer occurred in Canada in 2017.
Although high prevalence leads to burden on the population of the country, US and Canada have developed healthcare systems and hence spend a lot for the treatment and research in the oncology field. Hence, these countries attract a lot of market players.
Majority of the cancer supportive care drugs are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players, which has helped the market growth in these regions and has also increased competition for market share.
Customization of the Report
- Value chain analysis
- Consumer behavior analysis at country level
The report includes six parts, dealing with:
1.) basic information;
2.) the Asia Cancer Drugs Speaker Market;
3.) the North American Cancer Drugs Speaker Market;
4.) the European Cancer Drugs Speaker Market;
5.) market entry and investment feasibility;
6.) the report conclusion.
Table of Content:
1 Study Coverage
2 Executive Summary
3 Breakdown Data by Manufacturers
4 Breakdown Data by Type
5 Breakdown Data by Application
11 Company Profiles
12 Future Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
14 Value Chain and Sales Channels Analysis
15 Research Findings and Conclusion
The key insights of The report Research:
1.The report Research provides key statistics on the market status of the Cancer Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
2.The report Research provides a basic overview of the industry including its definition, applications and manufacturing technology.
3.The report Research presents the company profile, product specifications, capacity, production value, and 2019-2018 market shares for key vendors.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report Research estimates 2019-2025 market development trends of Cancer Drugs industry.
6.Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out
7.The report Research makes some important proposals for a new project of Cancer Drugs Industry before evaluating its feasibility.
Reasons to Purchase this Report:
* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
“Wise Guy Reports Is Part Of The Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Forecast Data For Industries And Governments Around The Globe. Wise Guy Reports Features An Exhaustive List Of Market Research Reports From Hundreds Of Publishers Worldwide. We Boast A Database Spanning Virtually Every Market Category And An Even More Comprehensive Collection Of Market Research Reports Under These Categories And Sub-Categories”.
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)